These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22744714)

  • 41. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.
    Mahon KL; Qu W; Devaney J; Paul C; Castillo L; Wykes RJ; Chatfield MD; Boyer MJ; Stockler MR; Marx G; Gurney H; Mallesara G; Molloy PL; Horvath LG; Clark SJ;
    Br J Cancer; 2014 Oct; 111(9):1802-9. PubMed ID: 25144624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
    Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
    J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Takahashi H; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Clin Breast Cancer; 2017 Feb; 17(1):61-69.e3. PubMed ID: 27395416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells.
    Kraguljac Kurtović N; Krajnović M; Bogdanović A; Suvajdžić N; Jovanović J; Dimitrijević B; Colović M; Krtolica K
    Med Oncol; 2012 Dec; 29(5):3547-56. PubMed ID: 22772967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.
    Khatami F; Teimoori-Toolabi L; Heshmat R; Nasiri S; Saffar H; Mohammadamoli M; Aghdam MH; Larijani B; Tavangar SM
    J Cell Biochem; 2019 Oct; 120(10):17422-17437. PubMed ID: 31127647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
    Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
    Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between
    Okita Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Kinoshita M; Nonaka M; Fujinaka T; Kanemura Y
    Clin Radiol; 2020 Aug; 75(8):622-628. PubMed ID: 32321646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients.
    Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM
    Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of dujieqing oral liquid on the promoter methylation of the MGMT gene in middle-and-late stage tumor patients receiving chemotherapy].
    Rong Z; Xu Y; Mo CM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1611-5. PubMed ID: 23469597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Eralp Y; Keskin S; Akışık E; Akışık E; İğci A; Müslümanoğlu M; Yılmaz S; Tunacı M; Çamlıca H; Tuzlalı S; Saip P; Dalay N; Özmen V; Topuz E
    Am J Clin Oncol; 2013 Jun; 36(3):215-23. PubMed ID: 22441341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis.
    An N; Shi Y; Ye P; Pan Z; Long X
    Cell Physiol Biochem; 2017; 42(6):2430-2440. PubMed ID: 28848211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapy.
    Cui Q; Jiang W; Guo J; Liu C; Li D; Wang X; Zeng Y
    Pathol Oncol Res; 2011 Sep; 17(3):587-91. PubMed ID: 21424568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis.
    Hashimoto K; Narita Y; Matsushita Y; Miyakita Y; Ono M; Kayama T; Shibui S
    Clin Transl Oncol; 2012 Jan; 14(1):31-5. PubMed ID: 22262716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas.
    Buttarelli FR; Massimino M; Antonelli M; Lauriola L; Nozza P; Donofrio V; Arcella A; Oliva MA; Di Rocco C; Giangaspero F
    Childs Nerv Syst; 2010 Aug; 26(8):1051-6. PubMed ID: 20552207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted Bisulfite Sequencing-Based Analysis of MGMT Promoter Methylation in Meningiomas.
    Bujko M; Kober P
    Asian Pac J Cancer Prev; 2016; 17(5):2727-8. PubMed ID: 27268659
    [No Abstract]   [Full Text] [Related]  

  • 58. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
    Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.